Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone ; volume:16 ; number:1 ; day:19 ; month:9 ; year:2018 ; pages:1-9 ; date:12.2018
World journal of surgical oncology ; 16, Heft 1 (19.9.2018), 1-9, 12.2018
- Creator
-
Engellau, Jacob
- Contributor
-
Seeger, Leanne
Grimer, Robert
Henshaw, Robert
Gelderblom, Hans
Choy, Edwin
Chawla, Sant
Reichardt, Peter
O’Neal, Michael
Feng, Amy
Jacobs, Ira
Roberts, Zachary J.
Braun, Ada
Bach, Bruce A.
SpringerLink (Online service)
- DOI
-
10.1186/s12957-018-1478-3
- URN
-
urn:nbn:de:101:1-2018110923190463047308
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Engellau, Jacob
- Seeger, Leanne
- Grimer, Robert
- Henshaw, Robert
- Gelderblom, Hans
- Choy, Edwin
- Chawla, Sant
- Reichardt, Peter
- O’Neal, Michael
- Feng, Amy
- Jacobs, Ira
- Roberts, Zachary J.
- Braun, Ada
- Bach, Bruce A.
- SpringerLink (Online service)
Other Objects (12)
Radiological findings of denosumab treatment for giant cell tumours of bone
Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment
Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation
Radiological findings of denosumab treatment for giant cell tumours of bone
Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment
Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation
Radiological findings of denosumab treatment for giant cell tumours of bone
Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Post-Denosumab-Treated Giant Cell Tumor of Bone: A Retrospective Histomorphological and Immunohistochemical Study
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment